Introduction 7.622384
: 2.5079741
Ċ 1.0427654
Mel 15.966974
an 3.3220403
oma 1.1363511
Ġis 0.7515273
Ġan 2.2377732
Ġaggressive 1.1029533
Ġform 2.280181
Ġof 0.0077802013
Ġskin 0.65993357
Ġcancer 0.020956026
Ġthat 0.90064013
Ġcan 2.57773
Ġmetast 5.599713
as 0.0041483464
ize 0.0050960844
Ġrapidly 5.2471285
Ġif 4.711087
Ġleft 0.67802435
Ġuntreated 0.32718486
. 0.2563881
ĠOver 5.0897455
Ġthe 0.99150866
Ġyears 1.825622
, 0.22020859
Ġadvancements 7.4651723
Ġin 0.24211201
Ġmedical 3.221514
Ġscience 2.214924
Ġhave 0.3856969
Ġled 2.194854
Ġto 0.06873922
Ġthe 1.0534102
Ġdevelopment 0.91418403
Ġof 0.03401764
Ġgroundbreaking 8.051143
Ġtreatments 1.2824163
, 2.5850341
Ġnotably 6.8684216
Ġimmune 7.2423363
Ġcheckpoint 2.4479673
Ġinhibitors 0.17612337
Ġand 2.7032309
Ġadj 5.5535064
u 0.79403937
vant 0.010207678
Ġtherapies 1.1069279
. 0.6468042
ĠThese 1.9750122
Ġnovel 5.0422287
Ġapproaches 2.3578427
Ġhave 1.1657661
Ġshown 4.653526
Ġgreat 1.6895031
Ġpotential 3.2296374
Ġin 1.0091199
Ġachieving 7.0908403
Ġlong 3.6042604
- 0.17245235
term 0.07584951
Ġremission 1.9524665
Ġand 2.0364573
Ġimproving 4.0035872
Ġsurvival 1.1796017
Ġrates 0.5773779
Ġfor 2.1182587
Ġpatients 0.8799514
Ġat 5.26802
Ġdifferent 7.7802753
Ġstages 0.069897294
Ġof 0.03329178
Ġmelan 4.0060873
oma 0.0045550694
. 1.1921357
ĠThis 4.1861477
Ġessay 6.7120137
Ġaims 2.5088372
Ġto 0.032039862
Ġdiscuss 2.7960968
Ġthe 0.69921196
Ġadvancements 5.232888
Ġin 0.6662546
Ġthese 2.850092
Ġtreatments 1.9016312
, 1.5222276
Ġtheir 2.6612086
Ġimplications 4.9869595
Ġfor 0.84582037
Ġpatients 2.0344653
, 0.86575884
Ġand 0.17469566
Ġillustrate 8.402217
Ġtheir 2.2940748
Ġimpact 3.957568
Ġon 0.2568969
Ġsurvival 3.5818005
Ġrates 0.76366526
Ġthrough 5.4342103
Ġthe 1.5810028
Ġcase 6.333491
Ġof 0.20352238
ĠMr 5.6347547
. 0.16295728
ĠB 4.4581776
. 0.7014817
Ċ 1.7985785
Ad 9.948912
vance 5.2620854
ments 0.03670847
Ġin 0.13741364
ĠMel 2.9178631
an 0.0016158307
oma 0.01341168
ĠTreatment 1.1251925
: 1.2307867
Ċ 1.540521
Imm 3.6454144
une 0.41470322
Ġcheckpoint 0.65057856
Ġinhibitors 0.08358391
Ġsuch 5.1874166
Ġas 0.0037651223
Ġp 3.7891593
emb 0.26034555
rol 0.009867995
iz 0.001959049
um 0.0019942268
ab 0.00090080523
Ġand 1.3206944
Ġn 4.3970733
iv 0.026174117
ol 0.18888652
um 0.0047732834
ab 0.0033837182
Ġhave 1.2695777
Ġrevolution 3.2831054
ized 0.026665187
Ġmelan 3.3336577
oma 0.0028421907
Ġtreatment 0.2223496
. 1.0845631
ĠThese 1.5960379
Ġdrugs 1.5757987
Ġwork 2.8821106
Ġby 0.11131651
Ġblocking 1.077764
Ġthe 0.72225827
Ġinteraction 5.010207
Ġbetween 0.7198895
Ġcancer 3.314071
Ġcells 0.28104386
Ġand 0.13013452
Ġimmune 1.9928385
Ġinhibit 12.245607
ory 0.0387893
Ġmolecules 1.0537466
, 1.8286736
Ġthus 2.3053646
Ġactivating 7.354688
Ġthe 1.0988352
Ġimmune 0.7258859
Ġsystem 0.23270084
Ġto 0.7103816
Ġrecognize 3.6007626
Ġand 0.82877797
Ġeliminate 3.1993673
Ġcancer 0.8197779
Ġcells 0.25785622
. 0.40290722
ĠThey 3.4666693
Ġhave 1.6415622
Ġdemonstrated 3.9765744
Ġremarkable 3.450064
Ġsuccess 1.8051547
Ġin 0.20133477
Ġachieving 4.130619
Ġdurable 5.193972
Ġresponses 4.9781876
Ġand 2.4096787
Ġprolonged 5.5152564
Ġsurvival 0.29991388
Ġrates 0.6274598
Ġin 1.6916463
Ġmetast 5.218781
atic 0.039036065
Ġmelan 0.40780917
oma 0.055334687
Ġpatients 0.8215212
. 0.2754174
Ċ 0.9983421
Additionally 6.048933
, 0.0094118165
Ġadj 1.6706795
u 0.42248422
vant 0.0013026856
Ġtherapies 0.3040364
, 2.3942118
Ġsuch 0.92109156
Ġas 0.0066176206
Ġinter 4.947269
fer 0.89555347
on 0.07921504
Ġtherapy 5.818359
, 0.6492795
Ġtargeted 6.3468504
Ġtherapy 2.5043116
, 0.8322298
Ġand 0.3117076
Ġcancer 5.5442586
Ġvaccines 2.626583
, 0.33089846
Ġhave 0.2637285
Ġplayed 5.16227
Ġa 0.49876133
Ġpivotal 2.6205873
Ġrole 0.01064133
Ġin 0.037989747
Ġreducing 4.2944336
Ġdisease 4.931677
Ġrec 2.4343233
urrence 0.03292883
Ġand 1.0944701
Ġimproving 1.7017754
Ġoverall 3.3051383
Ġsurvival 0.081755795
Ġrates 0.34351397
Ġpost 8.872242
- 0.1337346
sur 5.3189692
gery 0.0006957804
. 0.20580222
ĠThese 1.536704
Ġtherapies 1.5176997
Ġare 1.8055602
Ġoften 3.934211
Ġtailored 6.1160727
Ġto 0.16026787
Ġthe 1.1498268
Ġspecific 1.4676787
Ġmolecular 4.0202093
Ġcharacteristics 3.3962276
Ġof 0.0936841
Ġmelan 1.9150877
oma 0.012442336
, 1.0409847
Ġensuring 5.0091476
Ġa 2.7137866
Ġpatient 3.8241866
- 2.5864823
centered 4.426596
Ġapproach 0.3871364
. 2.5018756
Ċ 0.85750586
Impl 8.190389
ications 0.028592503
Ġfor 0.30432168
ĠPatients 0.5958035
Ġat 4.648352
ĠDifferent 0.18198472
ĠSt 0.56555694
ages 5.0500123e-05
: 1.7286438
Ċ 0.013870295
For 4.251377
Ġpatients 0.6992759
Ġwith 2.3925874
Ġearly 2.584548
- 1.4622532
stage 0.046402242
Ġmelan 0.4769805
oma 0.0155975595
, 0.1550129
Ġimmune 6.3288517
Ġcheckpoint 0.013314125
Ġinhibitors 0.100982584
Ġhave 1.9987447
Ġshown 1.9160054
Ġpromising 3.1478992
Ġoutcomes 4.1213255
Ġfor 3.4309218
Ġreducing 4.2351556
Ġthe 1.7709764
Ġrisk 1.7211465
Ġof 0.111075364
Ġrec 1.3282044
urrence 0.011398144
. 1.2536507
ĠStudies 5.338269
Ġhave 0.62867963
Ġshown 0.4623521
Ġthat 0.31791568
Ġpatients 1.69691
Ġwith 1.4262189
ĠStage 4.003664
ĠIII 3.7396433
Ġmelan 1.7414002
oma 0.02281717
Ġwho 2.0517087
Ġreceive 2.0447927
Ġadj 3.083148
u 0.13292903
vant 0.0016964307
Ġtherapy 0.7299929
Ġwith 3.0216517
Ġimmune 3.5689185
Ġcheckpoint 0.005393699
Ġinhibitors 0.091207795
Ġexperienced 3.3491366
Ġsignificantly 2.3855398
Ġbetter 2.4486673
Ġrec 5.20968
urrence 0.015055318
- 0.75431305
free 0.0123405885
Ġsurvival 0.041517105
Ġcompared 2.3545654
Ġto 0.19301675
Ġtraditional 9.081427
Ġtreatments 2.9593105
. 0.6698261
ĠThis 3.1297154
Ġimplies 6.290642
Ġthat 0.07923524
Ġthese 1.9606705
Ġtherapies 1.5355735
Ġcan 1.7023649
Ġpotentially 3.2686992
Ġconvert 9.51196
Ġa 2.309148
Ġdeadly 6.9840302
Ġdisease 0.7441745
Ġinto 0.56614864
Ġa 0.26406053
Ġmanageable 0.4404077
Ġcondition 3.2240639
Ġin 3.7010996
Ġthe 1.5233519
Ġlong 1.9510176
Ġterm 0.9026773
. 0.1011262
Ċ 0.5585729
In 2.8546782
Ġpatients 2.967813
Ġwith 0.22736825
Ġadvanced 0.90823215
- 0.79777044
stage 0.008351011
Ġmelan 0.15058503
oma 0.0045842915
, 0.06782217
Ġimmune 2.0329435
Ġcheckpoint 0.0036029967
Ġinhibitors 0.034051
Ġhave 0.65526265
Ġprovided 5.387258
Ġpreviously 9.092608
Ġunseen 4.5779943
Ġlevels 4.8333254
Ġof 0.005150484
Ġcontrol 5.3173018
Ġover 1.7488928
Ġthe 1.0257415
Ġdisease 1.1514996
. 0.725846
ĠThe 2.9740307
Ġuse 3.5994222
Ġof 0.0044354396
Ġp 5.3634768
emb 0.02015771
rol 0.010471702
iz 0.00017258391
um 2.9519388e-05
ab 0.00030642524
Ġhas 2.2955532
Ġyielded 5.470588
Ġremarkable 3.0148232
Ġresults 0.9140392
, 2.4480834
Ġwith 1.3881202
Ġstudies 6.361304
Ġfinding 2.8859346
Ġthat 0.6652927
Ġpatients 1.4952884
Ġachieved 7.7697477
Ġhigher 4.756079
Ġobjective 7.1063147
Ġresponse 2.1816618
Ġrates 0.22982
Ġand 1.0506514
Ġlonger 2.1951723
Ġprogression 7.2130656
- 0.2338154
free 0.0007848969
Ġsurvival 0.07009572
Ġcompared 1.3446565
Ġto 0.034306776
Ġconventional 4.1296744
Ġchemotherapy 3.8463576
. 0.7373531
ĠThis 2.6521478
Ġoffers 6.9077983
Ġrenewed 6.302809
Ġhope 0.03685243
Ġand 4.2925854
Ġprolonged 10.299156
Ġsurvival 0.52623177
Ġfor 1.3730326
Ġindividuals 6.422454
Ġfacing 5.749494
Ġadvanced 3.6013494
Ġmelan 2.060019
oma 0.007971226
. 0.44738227
Ċ 0.17539579
The 3.1471896
ĠCase 4.575801
Ġof 0.05290795
ĠMr 0.117116876
. 0.035245262
ĠB 0.017657857
: 0.68907493
Ċ 0.13898875
To 5.340897
Ġillustrate 2.3270621
Ġthe 0.52284503
Ġimpact 1.1123093
Ġof 0.25798982
Ġimmune 1.5577693
Ġcheckpoint 0.0031757907
Ġinhibitors 0.15139128
Ġin 1.6330214
Ġmelan 1.8756214
oma 0.0034850389
Ġtreatment 1.2364985
, 0.09807874
Ġwe 1.8814185
Ġcan 3.8437986
Ġexamine 2.3593333
ĠMr 1.0461026
. 0.004758014
ĠB 0.020397546
's 1.4310154
Ġcase 0.7745664
. 0.29665503
ĠMr 0.88298565
. 0.009353816
ĠB 0.0053071696
Ġwas 1.577594
Ġdiagnosed 0.43717635
Ġwith 0.065961935
Ġmetast 3.412562
atic 0.0074179843
Ġmelan 0.12801151
oma 0.001954993
Ġand 4.6864953
Ġwas 2.6423786
Ġinitially 2.9863603
Ġresponding 9.089304
Ġpoorly 3.828395
Ġto 0.36418784
Ġtraditional 2.0915833
Ġtreatments 1.772778
. 0.559613
ĠHowever 3.234978
, 0.0060747648
Ġupon 5.49267
Ġstarting 3.872201
Ġp 1.3777432
emb 0.009860108
rol 0.008519922
iz 0.00035013165
um 2.6893982e-05
ab 0.00034548063
Ġtherapy 2.8839443
, 0.26277256
Ġhis 1.4522578
Ġtumor 2.7072673
Ġregress 5.821939
ions 3.3479645
Ġwere 2.3177733
Ġobserved 5.227604
, 2.5431433
Ġleading 3.5718985
Ġto 0.2766366
Ġa 1.1721128
Ġdurable 6.4712462
Ġresponse 0.53954756
Ġwith 3.725269
Ġno 2.81603
Ġdisease 6.792408
Ġprogression 1.184182
. 0.56665295
Ċ 1.610251
This 3.0149412
Ġcase 3.1653733
Ġexempl 3.43962
ifies 0.009141817
Ġthe 0.45970893
Ġpotential 2.2801602
Ġof 0.5504647
Ġimmune 0.7506944
Ġcheckpoint 0.0038995696
Ġinhibitors 0.08533409
Ġin 0.81513256
Ġachieving 5.611195
Ġlong 1.8948995
- 0.029687587
term 0.016375832
Ġremission 1.352963
Ġfor 2.055146
Ġpatients 0.44823033
Ġwith 0.78453237
Ġadvanced 1.3570937
Ġmelan 1.350406
oma 0.0033289366
. 0.1935053
ĠMr 2.9688985
. 0.00483701
ĠB 0.0035451518
's 0.92031235
Ġexperience 3.5701747
Ġhighlights 2.9031174
Ġhow 3.0510485
Ġtargeted 5.754525
Ġtherapies 0.5568688
Ġcan 0.79655296
Ġeffectively 4.2244897
Ġhalt 7.098612
Ġdisease 1.1158869
Ġprogression 0.26489082
, 2.0261786
Ġextending 5.882213
Ġsurvival 1.4905263
Ġand 1.7575678
Ġimproving 0.838566
Ġthe 2.4475725
Ġquality 0.7677572
Ġof 0.020036504
Ġlife 0.03538703
Ġfor 0.32559213
Ġpatients 0.4476196
Ġfacing 3.403857
Ġa 2.169297
Ġpreviously 7.558747
Ġbleak 6.6838827
Ġprog 0.42832142
nosis 0.0010984747
. 0.05355985
Ċ 0.32747287
Conclusion 2.9330373
: 0.028772162
Ċ 0.093674146
The 2.0209405
Ġadvancements 4.045746
Ġin 0.11777909
Ġmelan 1.5000399
oma 0.002660732
Ġtreatment 0.21654035
Ġthrough 5.325471
Ġimmune 2.6788046
Ġcheckpoint 0.0040771826
Ġinhibitors 0.08944021
Ġand 1.3788736
Ġadj 0.05764161
u 0.32148948
vant 0.0010559285
Ġtherapies 0.10016166
Ġhave 1.0509071
Ġsignificantly 4.220701
Ġtransformed 4.5681233
Ġthe 0.3860138
Ġprog 4.2433844
nosis 0.016533315
Ġand 1.8425249
Ġquality 1.7568474
Ġof 0.044663057
Ġlife 0.013024831
Ġfor 0.3103284
Ġpatients 0.2404448
Ġat 1.5241426
Ġdifferent 0.63323283
Ġstages 0.012272161
. 3.7962635
ĠThrough 4.4282537
Ġextensive 6.028197
Ġresearch 1.1439946
Ġand 1.2033415
Ġevidence 5.283504
, 3.0603423
Ġit 2.6081765
Ġis 0.4796161
Ġevident 3.3291209
Ġthat 0.0313975
Ġthese 0.51121855
Ġtreatments 1.4990927
Ġoffer 3.2235727
Ġthe 2.513059
Ġpotential 1.0677553
Ġfor 1.6280135
Ġlong 2.8330667
- 0.025068995
term 0.053569093
Ġremission 1.9631193
, 2.0742276
Ġparticularly 5.1236124
Ġwhen 2.539684
Ġcombined 0.9827201
Ġwith 0.012508725
Ġpersonalized 6.7876234
Ġadj 5.602497
u 0.093058705
vant 0.0004477438
Ġtherapies 0.55911726
. 0.51104903
ĠAs 4.0722604
Ġdemonstrated 7.1765056
Ġby 0.9291844
ĠMr 0.37235612
. 0.004390361
ĠB 0.0017397184
's 1.1474066
Ġcase 0.7922153
, 0.09125703
Ġthese 1.0711828
Ġadvancements 4.1607003
Ġbring 6.2678113
Ġhope 1.443927
Ġfor 1.996492
Ġpatients 0.99366033
Ġfacing 1.1805972
Ġadvanced 2.0333307
Ġmelan 0.24690112
oma 0.00506098
, 1.7236928
Ġpromising 6.5155015
Ġincreased 7.3570395
Ġsurvival 0.8258814
Ġrates 0.5218519
Ġand 1.033927
Ġimproved 0.7356717
Ġoverall 4.390028
Ġoutcomes 4.463726
. 0.3662236
ĠContinued 8.117429
Ġresearch 0.94204825
Ġand 1.3232007
Ġinnovation 3.1091413
Ġin 1.5398306
Ġthis 1.7769872
Ġfield 0.80762404
Ġhold 7.3370376
Ġpromise 3.4059696
Ġfor 0.47016793
Ġfurther 3.191128
Ġadvancements 2.6621895
, 3.1900892
Ġoffering 5.743151
Ġhope 1.8526635
Ġto 1.3431153
Ġcountless 5.6743546
Ġindividuals 2.7273417
Ġbattling 3.683018
Ġthis 1.2336514
Ġaggressive 4.93058
Ġform 0.8937934
Ġof 0.0029628242
Ġskin 0.54430884
Ġcancer 0.003953483
. 0.04546522
